COVID-19: US may approve Pfizer’s vaccine next week
COVID-19: US may approve Pfizer’s vaccine next week. Senior consultant of US Food and Drug Administration: Pfizer’s COVID-19 vaccine may be approved next week.
A senior vaccine consultant from the US Food and Drug Administration (FDA) revealed on Saturday (5th) that the country is expected to approve the use of Pfizer’s new coronavirus vaccine candidate next week.
According to the US “Capitol Hill” report, FDA Vaccine Advisory Committee member James Hildreth said in an interview with US media on the 5th that the agency will vote next Thursday on whether to provide emergency use authorization for Pfizer vaccine (EUA), and whether the vaccine will be distributed the next day (11th).
“Thursday, we will spend a day reviewing Pfizer’s data, and voting on that day after the review is over.” Hildres said, “If the FDA Commissioner decides to issue EUA on voting day, we may see vaccinations across the country begin. .”
Early data shows that Pfizer’s COVID-19 vaccine has an effective rate of 95%, and the UK is the first country to approve the emergency use of the vaccine. However, the UK rushed to the finish line first, igniting a war of words between the UK and the EU and the US. The EU and the US questioned that the UK is rushing to achieve results and the regulatory procedures are not rigorous.